TDOC Company Profile and Key Details
NYSE : TDOC
Teladoc Health
$7.08
0.03+0.43%
At Close 4:00 PM62.23
BESG ScoreESG Rating
Price Chart
Stock Price Today
Teladoc Health, Inc. (TDOC) stock surged +0.43%, trading at $7.08 on NYSE, up from the previous close of $7.05. The stock opened at $7.02, fluctuating between $6.98 and $7.12 in the recent session.
Stock Snapshot
7.05
Prev. Close
1.28B
Market Cap
6.98
Day Low
-7.3
P/E Ratio
-0.97
EPS (TTM)
1.17
Cash Flow per Share
7.02
Open
180.51M
Number of Shares
7.12
Day High
98.9%
Free Float in %
14.01
Book Value
2.76M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 08, 2026 | 7.02 | 7.12 | 6.98 | 7.08 | 2.75M |
| Jun 05, 2026 | 7.24 | 7.30 | 6.94 | 7.05 | 3.34M |
| Jun 04, 2026 | 7.19 | 7.57 | 7.14 | 7.31 | 3.44M |
| Jun 03, 2026 | 7.40 | 7.40 | 6.96 | 7.09 | 4.88M |
| Jun 01, 2026 | 7.66 | 7.97 | 7.58 | 7.91 | 4.82M |
| May 29, 2026 | 7.45 | 8.03 | 7.40 | 7.61 | 8.24M |
| May 28, 2026 | 6.97 | 7.70 | 6.66 | 7.51 | 8.62M |
| May 27, 2026 | 6.65 | 6.83 | 6.58 | 6.59 | 3.31M |
| May 26, 2026 | 6.60 | 6.82 | 6.55 | 6.59 | 3.86M |
| May 22, 2026 | 6.55 | 6.68 | 6.52 | 6.57 | 2.41M |
| May 21, 2026 | 6.35 | 6.57 | 6.29 | 6.57 | 3.17M |
| May 20, 2026 | 6.59 | 6.62 | 6.38 | 6.48 | 2.73M |
| May 19, 2026 | 6.34 | 6.68 | 6.32 | 6.61 | 3.7M |
| May 18, 2026 | 6.38 | 6.53 | 6.28 | 6.35 | 3.4M |
| May 15, 2026 | 6.51 | 6.62 | 6.26 | 6.36 | 4.38M |
| May 14, 2026 | 6.77 | 6.78 | 6.57 | 6.61 | 3.03M |
| May 13, 2026 | 6.66 | 6.87 | 6.55 | 6.79 | 3.56M |
| May 12, 2026 | 6.87 | 6.90 | 6.56 | 6.77 | 6.86M |
| May 11, 2026 | 7.20 | 7.28 | 6.91 | 6.92 | 4.67M |
| May 08, 2026 | 6.91 | 7.39 | 6.80 | 7.25 | 6.49M |
Contact Details
About Company
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Company Information
| Employees | 4620 |
| Beta | 2.08 |
| Sales or Revenue | $2.60B |
| 5Y Sales Change% | 1.528% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
Stock Peers
VEEV
-5.37-3.11%
Veeva Systems Inc.$167.24HNGE-0.76-1.19%
Hinge Health, Inc.$62.86CTEV1.23+4.76%
Claritev Corporation$27.07MPLN-0.36-1.53%
MultiPlan Corporation$23.15DOCS-0.29-1.41%
Doximity, Inc.$20.30AGTI-0.05-0.50%
Agiliti, Inc.$10.05PHR-0.2-2.10%
Phreesia, Inc.$9.34AMWL0.13+1.51%
American Well Corporation$8.75EVH0.44+10.43%
Evolent Health, Inc.$4.66UPH0.0251+9.13%
UpHealth, Inc.$0.30Company Overview
Teladoc Health, Inc. (NYSE:TDOC) closed at $7.08 USD, gaining $0.03 (0.43%) from the previous close of $7.05. The stock is currently mid-range between its 52-week high and low $4.40 and $9.77. With a market capitalization of about $1.28 billion, Teladoc Health, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.14). Key stats such as the average daily volume over the past year has been around 4.91 million shares, volume is running light vs its 52-week average. Headquartered in Purchase, NY, Teladoc Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Charles Divita, the company employs approximately 4,620 people and listed since June 30, 2015. Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally.
Technical Performance
TDOC has shown weak momentum, losing -16.28% over the past week and -28.84% over the past quarter, though year-to-date performance is down -13.29%. Short-term trend indicators are bullishly aligned (SMA20 9.35%, SMA50 -12.43%, SMA200 -27.13%). The stock’s 14-day RSI is 51.75 (neutral), while the ATR of 0.32 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -53.68% below its high and over 21.59% above its low. Average 10-day trading volume of 3.85 million shares is below the 3-month average of 4.83 million, indicating normal recent market interest.
Valuation Metrics
Teladoc Health, Inc. trades at a P/E ratio of -7.42, slightly below the S&P 500 average, with a price-to-sales ratio of 0.51 and a price-to-book ratio of 0.95 suggesting the stock is closer to book value. The P/FCF stands at 5.09, also above market averages.
Dividend & Fair Value
Teladoc Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $21.93. This means the shares are trading below this model’s fair value.
Earnings & Analyst Outlook
Teladoc Health, Inc. generated EPS of -$1.28 over the past year. Five-year average earnings growth is -33.66%. Wall Street analysts project EPS growth of 35.74% annually over the next five years. The latest quarter delivered EPS of -$0.36. The next quarter is forecast at -$0.26. Next year's EPS is expected at $13.28. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 2 Buy ratings, 20 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $6.00. The high target offers 69.49% upside. The low target suggests -15.25% downside. The mean target is $8.85. This offers 25.0% upside. Teladoc Health, Inc. earnings surprise history is a mixed track record. The quarter that ended April 29, 2026, missed forecasts by 5.52%. The prior quarter beat by -26.32%. Over the last six quarters, Apple has recorded several small beats. These include 33.33% in February 26, 2025.
Shareholding & Insider Activity
Teladoc Health, Inc. has 176.69 million shares outstanding. The public float is 174.77 million shares, elevated short interest at 14.95% of float. This equals 23.62 million shares. The short ratio is 3.1 days. Institutional investors hold 76.88% of the float. Insiders own 0.65%. GOREVIC JASON N holds 653.07 thousand shares, DIVITA CHARLES III has 364.78 thousand shares and Murthy Mala has 142.38 thousand shares. Over the past six months, insider transactions show net selling. They sold 161.08 thousand shares across 9 transactions.
Price Forecast & Outlook
Our AI price prediction model suggests that Teladoc Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 7.06%, with price expected at $7.58 by June 22, 2026, within a range of $7.16 to $7.99 3-Month Outlook: Projected fall of -33.19%, reaching $4.73 by September 03, 2026, with a range of $3.87 to $5.09. 1-Year Outlook: Projected gain of 66.67%, with price at $11.80 by June 08, 2027, within a range of $0.00 to $16.38.
Key Takeaways
Teladoc Health, Inc. (NYSE:TDOC) shares are down -13.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Teladoc Health, Inc. trading at a premium to the broader market with a P/E of -7.42. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $20.92, suggesting 195.48% upside. Our AI forecast model points to short-term strength (7.06% over two weeks), a medium-term fall (-33.19% over three months), and a longer-term gain (66.67% over one year), with expected trading ranges indicating moderate volatility.
Frequently Asked Questions
What is the current Teladoc Health, Inc. (TDOC) stock price?
Teladoc Health, Inc. (NYSE: TDOC) stock price is $7.08 in the last trading session. During the trading session, TDOC stock reached the peak price of $7.12 while $6.98 was the lowest point it dropped to. The percentage change in TDOC stock occurred in the recent session was 0.43% while the dollar amount for the price change in TDOC stock was $0.03.
TDOC's industry and sector of operation?
The NYSE listed TDOC is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Teladoc Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of TDOC?
Ms. Courtney Kraemer McLeod
Director of Communication
Mr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Jason Nathanial Gorevic
Chief Executive Officer & Director
Mr. Adam Christian Vandervoort
Chief Legal Officer & Sec.
Dr. George Byron Brooks
Co-Founder
Mr. Andrew Turitz
Executive Vice President of Corporation Devel.
Ms. Mala Murthy
Chief Financial Officer
Mr. Richard J. Napolitano
Senior Vice President, Chief Accounting Officer & Controller
Mr. Laizer D. Kornwasser
Pres of Enterprise Growth & Global Markets
Dr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Mike Waters
Chief Operating Officer
Mr. Patrick Thomas Feeley C.F.A., CPA
Vice President of Investor Relations
Ms. Stephany Verstraete
Chief Marketing Officer & Engagement Officer
Mr. Michael Waters
Chief Operating Officer
Director of Communication
Mr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Jason Nathanial Gorevic
Chief Executive Officer & Director
Mr. Adam Christian Vandervoort
Chief Legal Officer & Sec.
Dr. George Byron Brooks
Co-Founder
Mr. Andrew Turitz
Executive Vice President of Corporation Devel.
Ms. Mala Murthy
Chief Financial Officer
Mr. Richard J. Napolitano
Senior Vice President, Chief Accounting Officer & Controller
Mr. Laizer D. Kornwasser
Pres of Enterprise Growth & Global Markets
Dr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Mike Waters
Chief Operating Officer
Mr. Patrick Thomas Feeley C.F.A., CPA
Vice President of Investor Relations
Ms. Stephany Verstraete
Chief Marketing Officer & Engagement Officer
Mr. Michael Waters
Chief Operating Officer
How TDOC did perform over past 52-week?
TDOC's closing price is 60.91% higher than its 52-week low of $4.40 where as its distance from 52-week high of $9.77 is -27.53%.
How many employees does TDOC have?
Number of TDOC employees currently stands at 4,620.
Link for TDOC official website?
Official Website of TDOC is: https://www.teladochealth.com
How do I contact TDOC?
TDOC could be contacted at phone 203 635 2002 and can also be accessed through its website. TDOC operates from 2 Manhattanville Road, Purchase, NY 10577, United States.
How many shares of TDOC are traded daily?
TDOC stock volume for the day was 2.76M shares. The average number of TDOC shares traded daily for last 3 months was 4.91M.
What is the market cap of TDOC currently?
The market value of TDOC currently stands at $1.28B with its latest stock price at $7.08 and 180.51M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep